Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone Augmentation of Nicotine Patch Therapy
NCT00218153Phase 3Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in Tobacco Use Disorder (TUD), sponsored by National Institute on Drug Abuse. Started Nov 2000; status: completed.
02
Drugs
naltrexone
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00218153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218153.